Athreye, Suma; Kale, Dinar and Ramani, Shyama V.
PDF (Accepted Manuscript)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
|DOI (Digital Object Identifier) Link:||https://doi.org/10.1093/icc/dtp024|
|Google Scholar:||Look up in Google Scholar|
This article demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.
|Item Type:||Journal Article|
|Copyright Holders:||2009 he Author|
|Keywords:||international marketing; R&D management; Indian pharmaceutical sector; corporate strategy|
|Academic Unit/School:||Faculty of Arts and Social Sciences (FASS) > Politics, Philosophy, Economics, Development, Geography
Faculty of Arts and Social Sciences (FASS)
|Interdisciplinary Research Centre:||Innovation, Knowledge & Development research centre (IKD)
International Development & Inclusive Innovation
|Depositing User:||Users 3615 not found.|
|Date Deposited:||19 Aug 2010 15:26|
|Last Modified:||11 Feb 2017 02:18|
|Share this page:|
Download history for this item
These details should be considered as only a guide to the number of downloads performed manually. Algorithmic methods have been applied in an attempt to remove automated downloads from the displayed statistics but no guarantee can be made as to the accuracy of the figures.